Verified Nov 2026
Other
·

Cambridge, Massachusetts
·
Since 2010
Moderna is a biotechnology company headquartered in Cambridge, Massachusetts, founded in 2010. With approximately 4,700 employees and estimated revenue between $1–5 billion, it develops messenger RNA therapeutics and vaccines. The company markets the Spikevax COVID-19 vaccine and Mresvia RSV vaccine, with over 40 mRNA candidates in clinical trials targeting infectious diseases, cancer, and rare disorders.
Moderna at a glance
Revenue
$1-5B
Est. band
Employees
1,000-5,000
Founded
2010
Headquarters
Cambridge, Massachusetts
Import activity
416
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Sourcing and import activity
From US customs bill-of-lading records
US sea imports
416
Named foreign suppliers
42
Top origins
Belgium · Netherlands · China · Taiwan

Shared foreign counterparties do not establish that these companies buy from Moderna.
What this tells a buyer
Moderna received 416 shipments from suppliers across 14 countries, with top sources including China (1,538 shipments from one supplier alone), Belgium (335 shipments), and Taiwan (105 shipments).
The company operates an mRNA technology platform enabling rapid discovery and manufacturing of vaccines and treatments, with a pipeline spanning oncology, cardiovascular conditions, and rare genetic diseases.
Moderna maintains manufacturing and research facilities in Massachusetts and Indiana, and recently announced a strategic shift toward oncology with enhanced production capabilities.
Source: US customs bill-of-lading records and public filings · Last verified Nov 16, 2026
STABILITY SIGNALS
Operating
16 years in operation (founded 2010).
416 US import shipments on record.
Overview
Moderna is a biotechnology company headquartered in Cambridge, Massachusetts, founded in 2010. With approximately 4,700 employees and estimated revenue between $1–5 billion, it develops messenger RNA therapeutics and vaccines. The company markets the Spikevax COVID-19 vaccine and Mresvia RSV vaccine, with over 40 mRNA candidates in clinical trials targeting infectious diseases, cancer, and rare disorders.
At a glance
Attribute | Detail |
|---|---|
Founded | 2010 |
Headquarters | Cambridge, Massachusetts |
Employees | 1,000-5,000 |
Revenue | $1-5B (estimated) |
What Moderna makes
The company operates an mRNA technology platform enabling rapid discovery and manufacturing of vaccines and treatments, with a pipeline spanning oncology, cardiovascular conditions, and rare genetic diseases.
Trade and customs footprint
Moderna received 416 shipments from suppliers across 14 countries, with top sources including China (1,538 shipments from one supplier alone), Belgium (335 shipments), and Taiwan (105 shipments). US customs bill-of-lading records list 416 inbound shipments across 42 foreign suppliers, with top origins including Belgium · Netherlands · China · Taiwan.
Latest developments
2026-11-12 — Moderna preps Massachusetts site for cancer shot (MRNA:NASDAQ) | Seeking Alpha (seekingalpha.com)
2026-11-12 — Moderna Analyst Day: Details Strategic Shift Toward Oncology and Enhanced Production Capabilities (benzinga.com)
2026-02-11 — Mexico enlists Moderna to boost mRNA supply for respiratory diseases - Pharmaceutical Technology (pharmaceutical-technology.com)
2026-01-29 — Moderna Announces Strategic Collaboration with Recordati to Globally Commercialize Investigational Propionic Acidemia Therapeutic (mRNA-3927) (barchart.com)
2025-12-12 — Nanexa collaboration to enhance Moderna’s mRNA drug delivery | News | European Pharmaceutical Review (europeanpharmaceuticalreview.com)
2025-11-19 — Moderna to complete US mRNA manufacturing network with $140 million investment | Reuters (reuters.com)
Facilities
Moderna is headquartered in Cambridge, Massachusetts. Public sources also reference these locations:
Massachusetts — seekingalpha.com
Norwood, Massachusetts — modernatx.com
Norwood, MA — modernatx.com
Bloomington, Indiana — catalent.com
Company details
Moderna maintains manufacturing and research facilities in Massachusetts and Indiana, and recently announced a strategic shift toward oncology with enhanced production capabilities. Moderna was founded in 2010, has an estimated 1,000-5,000 employees, and is headquartered in Cambridge, Massachusetts. On the LightSource stability read it is rated "Operating": 16 years in operation (founded 2010). 416 US import shipments on record.
Frequently asked questions
What does Moderna do?
Moderna is a biotechnology company headquartered in Cambridge, Massachusetts, founded in 2010. With approximately 4,700 employees and estimated revenue between $1–5 billion, it develops messenger RNA therapeutics and vaccines. The company markets the Spikevax COVID-19 vaccine and Mresvia RSV vaccine, with over 40 mRNA candidates in clinical trials targeting infectious diseases, cancer, and rare disorders.
Where is Moderna headquartered?
Moderna is headquartered in Cambridge, Massachusetts (200 Technology Square, Cambridge, Massachusetts, 02139).
When was Moderna founded?
Moderna was founded in 2010.
How big is Moderna?
Moderna has an estimated 1,000-5,000 employees, with revenue in the $1-5B range (estimated).
Does Moderna import from overseas suppliers?
US customs bill-of-lading records show 416 inbound shipments for Moderna, with top origins including Belgium · Netherlands · China · Taiwan.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
